Business Description
![Lexicon Pharmaceuticals Inc Lexicon Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C00000830.png?14)
Lexicon Pharmaceuticals Inc
NAICS : 325414
SIC : 2836
ISIN : US5288723027
Share Class Description:
LXRX: Ordinary SharesDescription
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.08 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | -0.55 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -4.72 | |||||
Beneish M-Score | 4.12 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -71.5 | |||||
3-Year EBITDA Growth Rate | -25.8 | |||||
3-Year EPS without NRI Growth Rate | 22.5 | |||||
3-Year FCF Growth Rate | 17.2 | |||||
3-Year Book Growth Rate | -29.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 17.71 | |||||
Future 3-5Y Total Revenue Growth Rate | 394.9 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.38 | |||||
9-Day RSI | 53.92 | |||||
14-Day RSI | 51.12 | |||||
6-1 Month Momentum % | -12.6 | |||||
12-1 Month Momentum % | 26.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.51 | |||||
Quick Ratio | 11.49 | |||||
Cash Ratio | 11.12 | |||||
Days Inventory | 529.65 | |||||
Days Sales Outstanding | 123.48 | |||||
Days Payable | 15242.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20.1 | |||||
Shareholder Yield % | -6.22 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 92.48 | |||||
Operating Margin % | -5412.11 | |||||
Net Margin % | -5550.87 | |||||
FCF Margin % | -5380.94 | |||||
ROE % | -106.62 | |||||
ROA % | -62.64 | |||||
ROIC % | -314.66 | |||||
ROC (Joel Greenblatt) % | -2433.83 | |||||
ROCE % | -63.05 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 130.71 | |||||
PB Ratio | 2.76 | |||||
Price-to-Tangible-Book | 3.39 | |||||
EV-to-EBIT | -2.44 | |||||
EV-to-Forward-EBIT | -2.11 | |||||
EV-to-EBITDA | -2.44 | |||||
EV-to-Forward-EBITDA | -2.11 | |||||
EV-to-Revenue | 124.24 | |||||
EV-to-Forward-Revenue | 32.54 | |||||
EV-to-FCF | -2.31 | |||||
Price-to-Net-Current-Asset-Value | 3.52 | |||||
Price-to-Net-Cash | 3.73 | |||||
Earnings Yield (Greenblatt) % | -40.98 | |||||
FCF Yield % | -29.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LXRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lexicon Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 3.641 | ||
EPS (TTM) ($) | -0.78 | ||
Beta | 1.27 | ||
Volatility % | 92.51 | ||
14-Day RSI | 51.12 | ||
14-Day ATR ($) | 0.15127 | ||
20-Day SMA ($) | 1.7845 | ||
12-1 Month Momentum % | 26.14 | ||
52-Week Range ($) | 0.92 - 3.73 | ||
Shares Outstanding (Mil) | 361.49 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Lexicon Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Lexicon Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Lexicon Pharmaceuticals Inc Frequently Asked Questions
What is Lexicon Pharmaceuticals Inc(LXRX)'s stock price today?
The current price of LXRX is $1.83. The 52 week high of LXRX is $3.73 and 52 week low is $0.92.
When is next earnings date of Lexicon Pharmaceuticals Inc(LXRX)?
The next earnings date of Lexicon Pharmaceuticals Inc(LXRX) is 2024-11-08 Est..
Does Lexicon Pharmaceuticals Inc(LXRX) pay dividends? If so, how much?
Lexicon Pharmaceuticals Inc(LXRX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |